Vivus At Highs Of The Session (VUVS)

Shares of VIVUS, Inc. VVUS shares are higher today, gaining 96 cents to $7.27, a gain of over 15% after the company shared positive data on its weight loss drug, Qnexa. VIVUS, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for underserved markets in the United States.